HealthTree Logo
search more_vert
close
person Sign In / Create Account
Learning about CAR-T Therapy with Dr. Noopur Raje
Learning about CAR-T Therapy with Dr. Noopur Raje image
NorthEast Myeloma Community
event May 12, 2022 / 06:30PM - 08:00PM EDT

Event Description

How familiar are you with CAR T Therapy? With two FDA approved CAR T therapies and another on the horizon, we are learning about this promising therapy and what it might mean for myeloma patients in terms of a cure.

Schedule & Agenda

person
Introductions
06:30PM
Audrey Burton-Bethkee
Audrey introduces the agenda of the event and featured speaker Dr. Noopur Raje.
person
Member Spotlight
06:35PM
Ellen Reich
Ellen shares her myeloma journey, including her experience with CAR T.
person
Presentation
06:45PM
Dr. Noopur Raje
Dr. Raje talks about CAR T Therapy, how it works and what it might mean for myeloma patients in terms of getting closer to a cure.
person
Questions and Answers
07:25PM
Audience
Type your questions in the chat and we will answer them!

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Noopur Raje, MD
Noopur Raje, MD

Noopur Raje, MD, is director of the Center for Multiple Myeloma at Massachusetts General Hospital. She is also Associate Professor of Medicine at Harvard Medical School. Her primary focus is treating patients with multiple myeloma and related plasma cell disorders. Dr. Raje leads a dedicated clinical team engaged in investigator-initiated, multi-center national and international clinical trials, all aimed at developing new promising therapies for multiple myeloma. Her laboratory efforts are focused on identifying cellular signaling pathways that contribute to the survival and proliferation of myeloma cells in the bone environment for which targeting may result in improved therapeutic outcomes.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Sanofi
GSK
Regeneron
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube